EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In the business of base editors: Evolution from bench to bedside

Elizabeth M Porto, Alexis C Komor iD

PLOS Biology · 2023

DOI: 10.1371/journal.pbio.3002071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Elizabeth M Porto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, United States of America. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the advent of recombinant DNA technology in the 1970s, the idea of using gene therapies to treat human genetic diseases captured the interest and imagination of scientists around the world. Years later, enabled largely by the development of CRISPR-based genome editing tools, the field has exploded, with academic labs, startup biotechnology companies, and large pharmaceutical corporations working in concert to develop life-changing therapeutics. In this Essay, we highlight base editing technologies and their development from bench to bedside. Base editing, first reported in 2016, is capable of installing C•G to T•A and A•T to G•C point mutations, while largely circumventing some of the pitfalls of traditional CRISPR/Cas9 gene editing. Despite their youth, these technologies have been widely used by both academic labs and therapeutics-based companies. Here, we provide an overview of the mechanics of base editing and its use in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingHumansAdolescentGenetic EngineeringGenetic Therapy

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, United States of America.

ORCID-Profile: Alexis C Komor

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Porto, E. M., & Komor, A. C. (2023). In the business of base editors: Evolution from bench to bedside. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002071

Vancouver

Porto EM, Komor AC. In the business of base editors: Evolution from bench to bedside. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002071

BibTeX
@article{Porto2023,
  author = {Porto, Elizabeth M and Komor, Alexis C},
  title = {In the business of base editors: Evolution from bench to bedside},
  journal = {PLOS Biology},
  year = {2023},
  doi = {10.1371/journal.pbio.3002071}
}
Kostenlos starten →